Catalyst Crew Technologies Corp. (OTC: CCTC) announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary intended to support the company's telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela. The move is part of the company's broader strategy to strengthen localized healthcare infrastructure in emerging markets.
LataMed AI VE, C.A. is expected to serve as a principal localized operating entity for the phased deployment of Catalyst Crew's telehealth platform, healthcare delivery infrastructure, and regulatory progression efforts. Management anticipates operational activities through the subsidiary may commence in the coming weeks, subject to continued regulatory progression, operational readiness, and commercialization planning. The new subsidiary will work alongside the company's existing framework, including Inversiones Long 33, C.A., as part of a regional infrastructure strategy designed to enhance local regulatory flexibility, healthcare service operations, permit management, and long-term scalability.
Management believes that LataMed AI VE, C.A. will significantly improve the company's ability to manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate broader telehealth platform expansion across Venezuela and other targeted Latin American markets. The subsidiary is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management within the company's evolving Latin American healthcare ecosystem.
Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing at latamedai.org. The company is coordinating regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies Corp., stated: "The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution."
This announcement underscores Catalyst Crew's commitment to building an integrated healthcare technology platform for emerging markets, with an initial focus on Latin America. The company is executing its strategic transition into AI-enabled healthcare, pursuing opportunities in telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination. For more information, visit catalystcrewai.com or review the company's SEC filings at www.sec.gov.
